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Experience With Primary Liver Transplantation 
Across ABO Blood Groups 
R.D. Gordon, S. Iwatsuki, C.O. Esquivel, S. Todo, L. Makowka, A. Tzakis, 
J.W. Marsh, and T.E. Starzl 
THE LIVER has long been regarded as a privileged organ which can be trans-
planted across incompatible ABO blood 
groups with little risk of hyperacute rejection. l 
However, in a recent review of 671 first, 
second, and third liver transplants we found a 
significant advantage for ABO donor-recip-
ient identity for primary liver transplants.2 
Although a large number of ABO mis-
matched grafts were successful, graft survival 
for primary liver grafts between ABO identi-
cal donor-recipient pairs was significantly bet-
ter than grafts between ABO compatible but 
nonidentical or ABO incompatible donor-
recipient pairs. 
The extent to which urgency of transplanta-
tion influenced these results was not fully 
assessed. An urgent factor existed in many of 
the transplants between ABO mismatched 
donor-recipient pairs. We here report a review 
of 745 primary liver transplants performed 
between Jan I, 1981 and Dec 31, 1986 at the 
University Health Center of Pittsburgh in 
which the early outcome of primary liver 
transplantation across ABO blood groups was 
assessed in relationship to the urgency of 
transplantation. 
MATERIALS AND METHODS 
Case Material 
Seven hundred forty-five patients received primary 
liver transplants at the University Health Center of 
Pittsburgh between Jan I, 1981 and Dec 31, 1986. All 
patients were followed through March I, 1987. Immuno-
suppression was cyclosporine and prednisone as described 
elsewhere.3 Since December 1983, Orthocloneo OKT3 
monoclonal antibody (Ortho Pharmaceuticals, Raritan, 
NJ) has been given for ten to 21 days for treatment of 
acut.e cellular rejection of during periods of reduced 
cyc1osporine coverage. 
Recipient selection was based on medical need, esti-
mated liver size and body weight. Preference was usually 
given to ABO blood group identity except in cases of 
medical urgency or donor scarcity, such as for small 
children. HLA typing and lymphocytotoxic cross-match-
ing were done retrospectively and were not used in 
recipient selection. 
ABO Blood Group Matching 
The donor-recipient pairings according to ABO blood 
group are summarized in Table I and Fig 1. There were 
664 ABO identical pairings. ABO mismatched trans-
plants were divided into two classes: (I) ABO compatible 
but nonidentical grafts (0 to A, B, or AB; A or B to AB) 
in which a graft-v-host (GVH) response may occur, 
usually manifested by a self-limited hemolytic anemia 12 
to 21 days after transplantation" and (2) ABO incoinpat-
ible grafts (A to B; B to A; A, B, or AB to 0). There were 
62 ABO compatible but nonidentical (GVH) pairings and 
19 ABO incompatible pairings. 
There were 333 male and 412 female recipients. There 
was a higher porportion (55.6%) of males in the ABO 
incompatible pairings than in the ABO identical (44.6%) 
or GVH (42.9%) pairings, but recipient sex has no 
influence on graft survival. 
The patients ranged in age from 2 months to 76 years 
(mean 26.9 ± 19.4, SD years) including 289 children 
(less than 19 years of age) and 456 adults. The age 
distribution of the patients according to ABO blood group 
pairings is shown in Fig 2. A higher proportion of ABO 
mismatched grafts involved small children for whom the 
scarcity of organs is always severe. 
Indications for Liver Transplantation 
The indications for liver replacement are summarized 
in Fig 3. Cirrhosis (mostly chronic aggressive hepatitis 
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Table 1. Donor-Recipient ABO Matches 
Group 0 Group A Group B Group AB 
Group 0 316 3 2 
Group A 21 282 2 3 
Group B 18 9 57 
Group AB 3 16 4 9 
but also including some cases of cryptogenic and Laen-
nec's cirrhosis), primary biliary cirrhosis, sclerosing cho-
langitis, inborn errors of metabolism, and primary liver 
tumors were the most common indications in adults. 
Biliary atresia, inborn errors of metabolism, and cirrhosis 
were the most common indications in children. The 
majority of ABO mismatched transplants were per-
formed for biliary atresia and cirrhosis, two of the most 
common indications for transplantation in younger 
patients. 
Statistical Analysis 
Survival analysis was performed using BMDP IPC 
(BMDP Statistical Software, Los Angeles, CAl on an 
IBM/PC-AT microcomputer. 
RESULTS 
Patient Survival 
Early survival for the 745 patients is shown 
in Fig 4A and is 86.4% at 30 days at 72.4% at 
180 days. Survival of patients under 4 years of 
age, which includes 23.5% of the recipients of 
ABO mismatched grafts was not different 
than survival of older patients (Fig 4B). 
GROUP 0 
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Fig 1. ABO donor-recipient compatibility classified 
according to recipient ABO blood group. GVH (graft-
v-hostl refers to ABO compatible but not identical 
graft-recipient pairs (such as 0 to A. B. or AB). Most of 
the ABO mismatched grafts were given to recipients of 
A. B. and AB blood types •• Identical; l1li. GVH; ~K 
incompatible. 
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Fig 2. The age distribution of liver transplant recip-
ients. Many of the ABO mismatched grafts were given 
to younger patients. 1'!11. incompatible; l1li. GVH; •• ABO 
identical. 
Graft Survival 
Four hundred twenty-two (56.6%) of the 
745 grafts are functioning 3 months to more 
than 5 years after transplantation. In 139 
cases, patient death resulted in graft loss. The 
remaining grafts were lost when retransplan-
tation was performed for rejection (74 cases), 
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Fig 3. The major indications for liver transplanta-
tion according to ABO graft-recipient match. Most of 
the ABO mismatched grafts were given to recipients 
with chronic aggressive hepatitis (cirrhosis) or biliary 
atresia. the two most common indications for transplan-
tation ••• ABO identical; II. GVH; 1'!11. incompatible. 
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Fig 4. (A) Patient and pri-
mary graft survival for 745 liver 
transplant recipients. (B) Sur-
vival for recipients under 4 
years of age at the time of 
transplantation was not signifi-
cantly different than survival of 
patients over 4 years of age. 
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technical complications (63 cases), primary 
graft failure (44 cases), or graft infection (4 
cases). 59.4% of the ABO identical grafts are 
functioning, compared to 40.3% of the GYH 
(ABO compatible but mismatched) grafts 
and 42.1 % of the ABO incompatible grafts 
(P <.04, Fig 5). 
Early survival (out of 180 days) for the 745 
grafts is shown in Fig 4A. Thirty-day survival 
is 77.3% and 180-day survival is 63.7%. Early 
graft survival based on ABO match is shown 
in Fig 6A. Thirty-day graft survival is 79.0%, 
67.2%, and 52.6% for ABO identical, GYH, 
and ABO incompatible pairings, respectively, 
and 66.0%, 46.5%, and 39.5% at 180 days, 
respectively. There is a highly significant 
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Fig 5. The fate of 745 primary liver grafts according 
to graft-recipient ABO match. Significantly more grafts 
were lost in the ABO mismatched cases .•• functioning; 
l1li. retransplanted; ~K died. 
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advantage in early graft survival for ABO 
identical grafts when compared to the two 
classes of ABO mismatched grafts 
(P < .002). 
The Factor of Clinical Urgency 
Our last effort to develop a clinical index to 
relate transplant outcome to pretransplant 
clinical risk factors such as serum bilirubin, 
prothrombin time, previous biliary or porto-
systemic shunt surgery, ascites, nutritional 
status and encephalopathy showed a poor 
correlation between outcome and risk factor 
score for most patients.5 For purposes of the 
present study, we considered a transplant to 
be urgent only for recipients with severe 
encephalopathy (grade 3 or grade 4), active 
gastrointestinal bleeding, or in intensive care 
at the time of transplantation. Survival of 
such urgent patients was significantly less 
than survival for other patients (P < .01). 
Each case of transplantation between ABO 
mismatched donor and recipient pairs was 
retrospectively reviewed to determine whether 
or not the patient was transplanted in such 
urgent circumstances. For the ABO identical 
grafts, it was not feasible to individually 
review all 664 cases. However, the patient 
status at the time of transplantation is kept in 
a computer registry and it was thus possible in 
many of cases to determine whether or not a 
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Fig 6. (AI Survival for 745 primary liver transplants based on donor-recipient ABO match. (BI Survival based on 
donor-recipient ABO match for primary liver transplants in patients considered clinically stable at the time of 
transplantation. Ie) Survival based on donor-recipient match for primary liver failure with graft loss to technical 
failure excluded. ABO compatible but not identical IGVH) and ABO compatible donor-recipient combinations have 
been pooled into a single class of "not identical." 
patient was in intensive care just prior to 
transplantation. There is a significantly 
higher proportion of urgent patients in the 
ABO mismatched graft-recipient classes 
(P < ,01, Fig 7). 
Figure 6B presents an analysis of the sur-
vival data when only patients considered sta-
ble at the time of transplantation are included. 
Even with the urgent cases removed from 
consideration for all the ABO mismatched 
(and for at least some of the ABO identical) 
grafts, early graft survival for ABO mis-
matched grafts is significantly less than sur-
vival for ABO identical grafts (P < .05). 
Technical Graft Losses 
Another possible source of bias in the data 
is graft loss from technical complications 
including hepatic artery or portal vein throm-
bosis or major biliary tract complications. For 
example, one ABO incompatible graft was 
lost when a patient with an anomalous 
superior vena cava developed fatal cerebral 
edema while on veno-venous bypass during 
the anhepatic phase of surgery. Obviously loss 
of this graft had nothing to do with the ABO 
mismatch. 
Figure 6C shows graft survival with techni-
cal graft losses removed from the analysis. 
The difference in survival between ABO iden-
tical and ABO mismatched grafts is not statis-
tically significant (Breslow, P = .11 and Man-
tel-Cox, P = .07). However, if both classes of 
ABO mismatched grafts are combined, the 
difference in survival between ABO identical 
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Fig 7. Donor-recipient ABO matches classified 
according to the clinical urgency at the time of trans-
plantation. This is a significantly higher proportion of 
urgent cases in the ABO mismatched groups . •• stable; 
III. urgent. 
ABO BLOOD GROUPS IN LIVER TRANSPLANTATION 
and ABO nonidentical grafts, with technical 
losses excluded, is significant (P < .05). 
DISCUSSION 
The presence of preformed antibody to 
donor transplantation antigens such as ABO 
blood group substances or to HLA antigens 
remains the most prohibitive barrier in renal 
transplantation. In liver transplantation, the 
frequency with which successful transplanta-
tion can be accomplished in the presence of 
preformed antibody to ABO blood group anti-
gens or antidonor lymphocytotoxic antibodl 
stands in striking contrast to the typical 
course of events in renal transplantation. 
The results of this study support our previ-
ous report that liver transplantation across 
ABO blood groups is usually successful, but 
not without risk.2 Even when the data are 
adjusted to remove very high risk patients, 
there remains a statistically significant advan-
tage in survival for ABO identical grafts. We, 
therefore, continue to give preference to ABO 
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compatibility in the selection of liver trans-
plant recipients, except in cases where medi-
cal urgency and donor scarcity justify taking 
an extra risk. 
Part of the disadvantage in graft survival 
associated with ABO mismatched grafts may 
lie in the added complexity of clinical manag-
ment that may result when graft-v-host dis-
ease (GVHD) is present. Inappropriate 
changes in therapy, especially in immunosup-
pression, might complicate the course of 
patients with ABO mismatched grafts. 
In this retrospective analysis, data were not 
available to assess the significance of preexist-
ing recipient anti-A or anti-B isoagglutinating 
antibody titers in the recipients of ABO 
incompatible grafts. Further studies are 
clearly warranted and are underway at this 
and other liver transplant centers. Only a 
deliberate prospective analysis of individual 
cases will clarify the nature of the increased 
risk of liver transplantation across ABO blood 
groups. 
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